Beyond Meat Inc. Beyond Meat (BYND) is trying to give investors something to chew on besides its dismal stock chart. On Thursday, the company announced that more than 20 of its products have earned a Clean Label Project Certification. Think of it as a third-party stamp of approval, verifying the products have been tested for contaminants like heavy metals and pesticides.
The newly certified lineup includes the Beyond Steak Filet, Beyond Ground Original, and the company's new Beyond Immerse protein drinks in flavors like Peach Mango and Orange Tangerine. The drinks are notable for being the first ready-to-drink protein beverages to get this particular certification. The company says this milestone underscores its commitment to transparency and ingredient quality, aiming for standards that go beyond what regulators require.
It's a positive PR move for a brand that's been battered. But for investors, the big question is whether a cleaner label can help clean up the stock's performance.
Technical Analysis
Let's look at the numbers. Technically, the picture isn't pretty. Beyond Meat is currently trading about 9% below its 20-day simple moving average and over 13% below its 50-day average. That's a classic sign of a bearish trend in the short term.
Zooming out, the view gets worse. Over the past 12 months, shares have plummeted nearly 80%. They're hanging out much closer to their 52-week lows than their highs. The Relative Strength Index (RSI) sits at 43.08, which is considered neutral—neither screaming "oversold" nor "overbought." Meanwhile, the MACD indicator is negative and below its signal line, suggesting bearish pressure is still in play.
So, you've got neutral momentum from one indicator and bearish from another. The technical takeaway? Mixed, but leaning negative. Traders are watching key resistance at 82 cents and key support at 50 cents.
Earnings & Analyst Outlook
The next major event is earnings, confirmed for March 25, 2026. The estimates tell a story of a company still trying to find its footing. Analysts expect a loss of 11 cents per share. That's actually an improvement from the loss of 65 cents a year ago, so progress on the bottom line. However, revenue is expected to come in at $63.05 million, down from $76.66 million previously.
The analyst community isn't exactly bullish. The consensus rating on the stock is a Sell. Recent actions have been overwhelmingly cautious:
- Mizuho: Maintained Underperform and lowered its price target to $1.00 (Nov. 13, 2025).
- Barclays: Maintained Underweight and lowered its price target to $1.00 (Nov. 12, 2025).
- BTIG: Maintained a Neutral rating (Oct. 24, 2025).
In short, Wall Street sees the path to profitability as long and the near-term revenue trends as concerning.
